DGX Technical Analysis
As of date:7/13/2020
DGX stock price:119.14
DGX 50 DMA:112.47
DGX 200 DMA:104.04
DGX MACD (200-50):-8.43
DGX RSI:69.08
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)69.08
Extremely
Oversold

Also see:
DGX Market Cap History
DGX Shares Outstanding History
DGX YTD Return

Quotes delayed 20 minutes
Get Free SEC filing alerts for DGX:
DGX SEC Filing Email Alerts ServiceExternal link

Notable Two Hundred Day Moving Average Cross - DCPH
24 minutes ago


ADUS Crosses Below Key Moving Average Level
39 minutes ago


VRSN Crosses Below Key Moving Average Level
47 minutes ago


PSTG Makes Notable Cross Below Critical Moving Average
56 minutes ago


PKG Makes Bullish Cross Above Critical Moving Average
1 hour, 12 minutes ago


VGM Makes Notable Cross Below Critical Moving Average
1 hour, 12 minutes ago


AMETEK (AME) Shares Cross Above 200 DMA
1 hour, 20 minutes ago


CRTX Makes Notable Cross Below Critical Moving Average
18 hours, 55 minutes ago


ATNX Crosses Below Key Moving Average Level
18 hours, 55 minutes ago


HOOK Crosses Below Key Moving Average Level
18 hours, 55 minutes ago


Notable Two Hundred Day Moving Average Cross - APPN
18 hours, 55 minutes ago


Prevail Therapeutics (PRVL) Shares Cross Below 200 DMA
18 hours, 55 minutes ago


Restaurant Brands Breaks Below 200-Day Moving Average - Notable for RTBRF
19 hours, 29 minutes ago


CNXN Crosses Below Key Moving Average Level
19 hours, 40 minutes ago


Anaplan (PLAN) Shares Cross Below 200 DMA
19 hours, 40 minutes ago


More Technical Analysis News

DGX Technical AnalysisDGX RSI
Quest Diagnostics provides diagnostic information services. Co.'s diagnostic information segment provides information based on the menu of routine, non-routine and clinical testing and anatomic pathology testing, and other diagnostic information services. Co.'s testing capabilities, includes services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and provides tests in several fields, including endocrinology, immunology, neurology and oncology. Co.'s diagnostic solutions provides risk assessment services for the life insurance industry, as well as provides healthcare organizations and clinicians health information technology solutions.

When researching a stock like Quest Diagnostics, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DGX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DGX stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
DGX DMADGX MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quest Diagnostics (DGX) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

DHR Technical Analysis
DVA Technical Analysis
EW Technical Analysis
GILD Technical Analysis
HCA Technical Analysis
HOLX Technical Analysis
HSIC Technical Analysis
IDXX Technical Analysis
ILMN Technical Analysis
INCY Technical Analysis
More Healthcare companies »

 

DGX Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.